Scanlan Sean F.'s Form 4 filing
Treace Medical Concepts, Inc. (TMCI) · filed Mar 10, 2023
- Accession no.
- 0001209191-23-018042
- Filed
- Mar 10, 2023
- Trade date
- Mar 9-10, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $12.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Scanlan Sean F.CIK 0001856371 | Officer (Chief Innovation Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | Common Stock | SSaleDisposed | −505 | $24.41 | −$12,327.05 | 9,470 | Direct | |
| Mar 10, 2023 | Common Stock | AGrant or awardAcquired | +22,925 | $0.00 | $0 | 32,395 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | Stock Option (Right to Buy) | AGrant or awardDisposed | −51,950 | $0.00 | $0 | 51,950 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.